Stay updated on TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.6.6 has been added to the record history, and the previous revision v3.6.5 has been removed, updating the page’s revision timeline.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe record history now displays a new Revision: v3.6.5 entry, indicating the study record has been updated to a newer version and replacing the previous v3.6.4 entry.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a maintenance update to the page's revision history display.SummaryDifference0.1%

- Check67 days agoChange DetectedA new Revision: v3.6.3 entry was added to the study history and the previous Revision: v3.6.2 entry was removed. This reflects a platform update shown in the record history.SummaryDifference0.1%

- Check74 days agoChange DetectedNew revision entry v3.6.2 appears in the study record history, replacing the previous v3.6.0. This indicates a minor backend or documentation update to the page rather than changes to study content or participant data.SummaryDifference0.1%

- Check88 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating the study is not enrolling new participants. The record's revision history shows the current version as v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

Stay in the know with updates to TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.